AP751A - Oxa-and thia-diazole muscarinic receptor antagonists. - Google Patents

Oxa-and thia-diazole muscarinic receptor antagonists. Download PDF

Info

Publication number
AP751A
AP751A APAP/P/1997/000930A AP9700930A AP751A AP 751 A AP751 A AP 751A AP 9700930 A AP9700930 A AP 9700930A AP 751 A AP751 A AP 751A
Authority
AP
ARIPO
Prior art keywords
compound
formula
alkyl
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
APAP/P/1997/000930A
Other languages
English (en)
Other versions
AP9700930A0 (en
Inventor
Alexander Roderick Mackenzie
Anthony Wood
Robert John Bass
Original Assignee
Pfizer Res & Development Company N V /S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Development Company N V /S A filed Critical Pfizer Res & Development Company N V /S A
Publication of AP9700930A0 publication Critical patent/AP9700930A0/xx
Application granted granted Critical
Publication of AP751A publication Critical patent/AP751A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
APAP/P/1997/000930A 1996-02-22 1997-02-20 Oxa-and thia-diazole muscarinic receptor antagonists. AP751A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603755.1A GB9603755D0 (en) 1996-02-22 1996-02-22 Therapeutic agents

Publications (2)

Publication Number Publication Date
AP9700930A0 AP9700930A0 (en) 1997-04-30
AP751A true AP751A (en) 1999-07-12

Family

ID=10789217

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/000930A AP751A (en) 1996-02-22 1997-02-20 Oxa-and thia-diazole muscarinic receptor antagonists.

Country Status (43)

Country Link
US (1) US5977142A (xx)
EP (1) EP0885218B1 (xx)
JP (1) JP3148252B2 (xx)
KR (1) KR100315934B1 (xx)
CN (1) CN1089340C (xx)
AP (1) AP751A (xx)
AR (1) AR005916A1 (xx)
AT (1) ATE200899T1 (xx)
AU (1) AU712230B2 (xx)
BG (2) BG63971B1 (xx)
BR (1) BR9707733A (xx)
CA (1) CA2247164C (xx)
CO (1) CO4650040A1 (xx)
CZ (1) CZ292650B6 (xx)
DE (1) DE69704701T2 (xx)
DK (1) DK0885218T3 (xx)
DZ (1) DZ2181A1 (xx)
ES (1) ES2156357T3 (xx)
GB (1) GB9603755D0 (xx)
GR (1) GR3036032T3 (xx)
HK (1) HK1018274A1 (xx)
HN (1) HN1997000020A (xx)
HR (1) HRP970098B1 (xx)
HU (1) HUP9900501A3 (xx)
ID (1) ID16642A (xx)
IL (1) IL125413A (xx)
IS (1) IS4803A (xx)
MY (1) MY129729A (xx)
NO (1) NO313414B1 (xx)
NZ (1) NZ331039A (xx)
OA (1) OA10838A (xx)
PE (1) PE42798A1 (xx)
PL (1) PL186879B1 (xx)
PT (1) PT885218E (xx)
RU (1) RU2162848C2 (xx)
SK (1) SK283461B6 (xx)
TN (1) TNSN97039A1 (xx)
TR (1) TR199801644T2 (xx)
TW (1) TW492961B (xx)
UA (1) UA61068C2 (xx)
WO (1) WO1997030994A1 (xx)
YU (1) YU35698A (xx)
ZA (1) ZA971513B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
GB0510139D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
GB0510141D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B3
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
JP2010501533A (ja) * 2006-08-21 2010-01-21 アージェンタ ディスカバリー リミテッド Ｍ３レセプター調節物質として有用な窒素含有複素環化合物
WO2008096093A1 (en) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Oxazole and thiazole derivatives and their uses
JP5373634B2 (ja) * 2007-02-07 2013-12-18 パルメイゲン・セラピューティクス・（シナジー）・リミテッド ムスカリンｍ３アンタゴニストのナパジシル酸塩
GB0702416D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702382D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New salt
GB0702414D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd Oxazole and thiazole derivatives and their uses 2
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
EP2121688A1 (en) * 2007-02-15 2009-11-25 Argenta Discovery Ltd Heterocyclic derivatives as m3 muscarinic receptors
WO2009098453A1 (en) * 2008-02-06 2009-08-13 Astrazeneca Ab Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (en) * 2008-08-12 2010-02-18 Argenta Discovery Limited Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated
JP2014065387A (ja) * 2012-09-25 2014-04-17 Showa Corp 自動二輪車の車高調整装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323864A2 (en) * 1988-01-08 1989-07-12 Merck Sharp & Dohme Ltd. Lipophilic oxadiazoles
WO1993013083A1 (en) * 1991-12-31 1993-07-08 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
TW360653B (en) * 1995-03-01 1999-06-11 Janssen Pharmaceutica Nv A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323864A2 (en) * 1988-01-08 1989-07-12 Merck Sharp & Dohme Ltd. Lipophilic oxadiazoles
WO1993013083A1 (en) * 1991-12-31 1993-07-08 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. MED. CHEM. VOL.33 NO.4, 1990, PP1128-1138 *

Also Published As

Publication number Publication date
ES2156357T3 (es) 2001-06-16
CA2247164C (en) 2004-11-16
AU1601497A (en) 1997-09-10
CZ267898A3 (cs) 1999-08-11
BG63971B1 (bg) 2003-08-29
ATE200899T1 (de) 2001-05-15
DE69704701T2 (de) 2001-08-16
CO4650040A1 (es) 1998-09-03
CZ292650B6 (cs) 2003-11-12
AR005916A1 (es) 1999-07-21
TNSN97039A1 (fr) 2005-03-15
PL186879B1 (pl) 2004-03-31
HUP9900501A3 (en) 2001-02-28
BG102699A (en) 1999-09-30
KR100315934B1 (ko) 2002-03-21
JP3148252B2 (ja) 2001-03-19
DK0885218T3 (da) 2001-05-28
YU35698A (sh) 1999-07-28
SK112398A3 (en) 2000-04-10
NO313414B1 (no) 2002-09-30
GB9603755D0 (en) 1996-04-24
RU2162848C2 (ru) 2001-02-10
NZ331039A (en) 1999-10-28
ZA971513B (en) 1998-08-21
IL125413A (en) 2002-09-12
PL328633A1 (en) 1999-02-15
PT885218E (pt) 2001-08-30
WO1997030994A1 (en) 1997-08-28
CN1089340C (zh) 2002-08-21
AP9700930A0 (en) 1997-04-30
BR9707733A (pt) 1999-07-27
DE69704701D1 (de) 2001-06-07
TW492961B (en) 2002-07-01
US5977142A (en) 1999-11-02
HN1997000020A (es) 1997-06-05
EP0885218B1 (en) 2001-05-02
ID16642A (id) 1997-10-23
NO983871L (no) 1998-08-21
PE42798A1 (es) 1998-08-18
IS4803A (is) 1998-07-21
CA2247164A1 (en) 1997-08-28
HK1018274A1 (en) 1999-12-17
EP0885218A1 (en) 1998-12-23
JPH11504051A (ja) 1999-04-06
IL125413A0 (en) 1999-03-12
GR3036032T3 (en) 2001-09-28
CN1211981A (zh) 1999-03-24
TR199801644T2 (xx) 1998-11-23
HRP970098A2 (en) 1999-04-30
UA61068C2 (en) 2003-11-17
SK283461B6 (sk) 2003-08-05
DZ2181A1 (fr) 2002-12-01
HRP970098B1 (en) 2001-12-31
AU712230B2 (en) 1999-11-04
KR19990087143A (ko) 1999-12-15
MY129729A (en) 2007-04-30
OA10838A (en) 2001-08-13
NO983871D0 (no) 1998-08-21
HUP9900501A2 (hu) 1999-06-28

Similar Documents

Publication Publication Date Title
AP751A (en) Oxa-and thia-diazole muscarinic receptor antagonists.
US8119661B2 (en) Piperidine derivatives and their use as muscarinic receptor modulators
JPH09508646A (ja) タキキニンアンタゴニストとしての（アゼチジン−１−イルアルキル）
IE904462A1 (en) Muscarinic receptor antagonists
US20090221642A1 (en) Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof-176
US20090221567A1 (en) Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
WO1991010647A1 (en) Muscarinic receptor antagonists
US5486527A (en) Anticholinergic agents
JP2002532480A (ja) モルホリノン及びモルホリン誘導体、ならびにその使用
JP2918508B2 (ja) アゼチジン類
CA2072575C (en) Anticholinergic agents
JPH0791268B2 (ja) ムスカリンレセプター拮抗薬
JP2002504082A (ja) アレルギー疾患の治療に有用な新規な置換されたｎ―メチル―ｎ―（４―（ピペリジン―１―イル）―２―（アリール）ブチル）ベンズアミド
EP0505379B1 (en) Muscarinic receptor antagonists
US20070142349A1 (en) 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
EP0328830A1 (en) 4-Heteropentacyclic-4- N-(phenyl)amido piperidine compounds